Track topics on Twitter Track topics that are important to you
Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research publishing June 29 in the open access journal PLOS Biology by Jonathan Kimmelman and colleagues from McGill University suggests.
Original Article: Cancer researchers overestimate reproducibility of preclinical studiesNEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...